J Korean Med Sci.  2007 Apr;22(2):283-289. 10.3346/jkms.2007.22.2.283.

Promotive Effect of Minoxidil Combined with All-trans Retinoic Acid (tretinoin) on Human Hair Growth in Vitro

• Kwon OS
• Pyo HK
• Oh YJ
• Han JH
• Lee SR
• Chung JH
• Eun HC
• Kim KH

• KMID: 1713189
• DOI: http://doi.org/10.3346/jkms.2007.22.2.283

Abstract

Minoxidil induces hair growth in male pattern baldness and prolongs the anagen phase. All-trans retinoic acid (ATRA) has been reported to act synergistically with minoxidil in vivo: they can enhance more dense hair regrowth than either compound alone. We evaluated the effect of minoxidil combined with ATRA on hair growth in vitro. The effect of co-treatment of minoxidil and ATRA on hair growth was studied in hair follicle organ culture. In cultured human dermal papilla cells (DPCs) and normal human epidermal keratinocytes, the expressions of Erk, Akt, Bcl-2, Bax, P53 and P21 were evaluated by immunoblot analysis. Minoxidil plus ATRA additively promoted hair growth in vitro, compared with minoxidil alone. In addition, minoxidil plus ATRA elevated phosphorylated Erk, phosphorylated Akt and the ratio of Bcl-2/Bax, but decreased the expressions of P53 and P21 more effectively than by minoxidil alone. Our results suggest that minoxidil plus ATRA would additively enhance hair growth by mediating dual functions: 1) the prolongation of cell survival by activating the Erk and Akt signaling pathways, and 2) the prevention of apoptosis of DPCs and epithelial cells by increasing the ratio of Bcl-2/Bax and downregulating the expressions of P53 and P21.

Keyword

Minoxidil; Tretinoin; Hair Follicle; Hair Growth; Dermal Papilla Cell; Keratinocytes

MeSH Terms

Tretinoin/*administration & dosage
Minoxidil/*administration & dosage
Keratolytic Agents/administration & dosage
Humans
Hair/cytology/*drug effects/*growth & development
Drug Combinations
Dose-Response Relationship, Drug
Cells, Cultured
Cell Proliferation/drug effects

Figure

• 

  Fig. 1 The effect of minoxidil plus ATRA on hair growth in vitro. Hair follicle organ culture was performed in triplicates with hair follicles obtained from the occipital scalp of three volunteers. Hair growth is enhanced by minoxidil at 1 µM. Minoxidil plus ATRA promotes hair growth more significantly, especially at a concentration of 1 µM minoxidil and 1 nM ATRA. Moreover, the increase in hair growth was significant compared with minoxidil alone. Values were obtained after cumulative growth of 15 hair follicles per each growth condition for 12 days and shown as the means±SEM. *, p<0.05; †, p<0.01.

• 

  Fig. 2 The effect of minoxidil and ATRA on the p-Erk and on total Erk in (A) DPCs and in (B) NHK. The level of p-Erk increased significantly after treatment of minoxidil, and minoxidil plus ATRA more enhanced the expression of p-Erk. The representative bands of triplicate experiments are shown. The values shown are the means±SEM of % elevation compared with the vehicle-treated control from three different DPCs and NHK cultures. *, p<0.05, compared with the vehicle-treated control. p-Erk, phosphorylated Erk; T-Erk, total Erk; M, minoxidil.

• 

  Fig. 3 The increase of p-Akt expression by minoxidil and ATRA. (A) In DPCs, minoxidil increases p-Akt, moreover, minoxidil plus ATRA more significantly elevates the p-Akt level. (B) In NHK, minoxidil alone and minoxidil plus ATRA increase p-Akt expression, however, they were statistically insignificant. The blotted bands are the representative of triplicate experiments. The values are shown as the means±SEM of % elevation compared with controls. *, p<0.05, compared with controls treated with the vehicle. p-Akt, phosphorylated Akt; T-Akt, total Akt; M, minoxidil.

• 

  Fig. 4 The effect of minoxidil and ATRA on the expression of Bcl-2 and Bax protein in DPCs and NHK. Compared with vehicle-treated control, minoxidil plus ATRA significantly increases the expression of Bcl-2 in DPCs (A) and in NHK (B). (C) Minoxidil significantly decreases the expression of Bax. Minoxidil plus ATRA suppresses the expression of Bax more efficiently in DPCs. (D) Expression of Bax in NHK is also significantly decreased by minoxidil plus ATRA. The bands are the representatives of triplicate experiments. The values are shown as the means±SEM of % elevation in comparison with the controls. *, p<0.05 compared with vehicle-treated control. M, minoxidil.

• 

  Fig. 5 The effects of minoxidil and ATRA on the expressions of P53 and P21 protein in DPCs and NHK. (A) Minoxidil alone and minoxidil plus ATRA significantly suppress the expression of P53 protein in DPCs. (B) In NHK, minoxidil plus ATRA decreases P53 expression significantly. (C) In DPCs, Minoxidil significantly decreases the expression of P21. Minoxidil plus ATRA reduces the expression of P21 more significantly. (D) P21 expression is significantly downregulated with minoxidil plus ATRA. The bands are the representative of triplicate experiments. *, p<0.05 compared with the vehicle-treated control. The data are shown as the means±SEM of % elevation compared with controls from three different DPC and NHK cultures. M, minoxidil.

Reference

1. Tanigaki-Obana N, Ito M. Effects of cepharanthine and minoxidil on proliferation, differentiation and keratinization of cultured cells from the murine hair apparatus. Arch Dermatol Res. 1992. 284:290–296.

2. Lee WS, Ahn HJ, Kim YH. The effect of coapplication of capsaicin and minoxidil on the murine hair growth. Korean J Dermatol. 2003. 41:451–460.

3. Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004. 150:186–194.

4. Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA, Cotsarelis G. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol. 2004. 22:411–417.

5. Bergfeld WF. Retinoids and hair growth. J Am Acad Dermatol. 1998. 39:S86–S89.

6. Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J. 1996. 10:1002–1013.

7. Bazzano G, Terezakis N, Attia H, Bazzano A, Dover R, Fenton D, Mandir N, Celleno L, Tamburro M, Jaconi S. Effect of retinoids on follicular cells. J Invest Dermatol. 1993. 101:138S–142S.

8. Bazzano GS, Terezakis N, Galen W. Topical tretinoin for hair growth promotion. J Am Acad Dermatol. 1986. 15:880–883. 890–893.

9. Ferry JJ, Forbes KK, VanderLugt JT, Szpunar GJ. Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution. Clin Pharmacol Ther. 1990. 47:439–446.

10. Han JH, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci. 2004. 34:91–98.

11. Messenger AG. The culture of dermal papilla cells from human hair follicles. Br J Dermatol. 1984. 110:685–689.

12. Philpott MP, Green MR, Kealey T. Human hair growth in vitro. J Cell Sci. 1990. 97:463–471.

13. Randall VA, Thornton MJ, Redfern CP. Dermal papilla cells from human hair follicles express mRNA for retinoic acid receptors in culture. Ann N Y Acad Sci. 1991. 642:457–458.

14. Boyera N, Galey I, Bernard BA. Biphasic effects of minoxidil on the proliferation and differentiation of normal human keratinocytes. Skin Pharmacol. 1997. 10:206–220.

15. Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol. 1983. 81:33s–40s.

16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983. 65:55–63.

17. Kim R, Tanabe K, Emi M, Uchida Y, Inoue H, Toge T. Inducing cancer cell death by targeting transcription factors. Anticancer Drugs. 2003. 14:3–11.

18. Skov MJ, Quigley JW, Bucks DA. Topical delivery system for tretinoin: research and clinical implications. J Pharm Sci. 1997. 86:1138–1143.

19. You YO, Lee G, Min BM. Retinoic acid extends the in vitro life span of normal human oral keratinocytes by decreasing p16 (INK4A) expression and maintaining telomerase activity. Biochem Biophys Res Commun. 2000. 268:268–274.

20. Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997. 9:180–186.

21. Bost F, Caron L, Marchetti I, Dani C, Le Marchand-Brustel Y, Binetruy B. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem J. 2002. 361:621–627.

22. Chung JH, Kang S, Varani J, Lin J, Fisher GJ, Voorhees JJ. Decreased extracellular-signal-regulated kinase and increased stress-activated MAP kinase activities in aged human skin in vivo. J Invest Dermatol. 2000. 115:177–182.

23. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, McCubrey JA. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway [Review]. Int J Oncol. 2003. 22:469–480.

24. Ahmad S, Singh N, Glazer RI. Role of AKT1 in 17beta-estradiol- and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol. 1999. 58:425–430.

25. Tang Y, Zhou H, Chen A, Pittman RN, Field J. The Akt proto-oncogene links Ras to Pak and cell survival signals. J Biol Chem. 2000. 275:9106–9109.

26. Chang F, Lee JT, Navolanic PM, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia. 2003. 17:590–603.

27. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003. 22:8590–8607.

28. McCubrey JA, Steelman LS, Blalock WL, Lee JT, Moye PW, Chang F, Pearce M, Shelton JG, White MK, Franklin RA, Pohnert SC. Synergistic effects of pi3k/akt on abrogation of cytokine-dependency induced by oncogenic raf. Adv Enzyme Regul. 2001. 41:289–323.

29. Stenn KS, Lawrence L, Veis D, Korsmeyer S, Seiberg M. Expression of the bcl-2 protooncogene in the cycling adult mouse hair follicle. J Invest Dermatol. 1994. 103:107–111.

30. Lindner G, Botchkarev VA, Botchkareva NV, Ling G, van der Veen C, Paus R. Analysis of apoptosis during hair follicle regression (catagen). Am J Pathol. 1997. 151:1601–1617.

31. Ferraris C, Cooklis M, Polakowska RR, Haake AR. Induction of apoptosis through the PKC pathway in cultured dermal papilla fibroblasts. Exp Cell Res. 1997. 234:37–46.

32. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998. 281:1322–1326.

33. Chung JJ, Cho S, Kwon YK, Kim DH, Kim K. Activation of retinoic acid receptor gamma induces proliferation of immortalized hippocampal progenitor cells. Brain Res Mol Brain Res. 2000. 83:52–62.

34. Reed JC, Miyashita T, Takayama S, Wang HG, Sato T, Krajewski S, Aime-Sempe C, Bodrug S, Kitada S, Hanada M. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem. 1996. 60:23–32.

35. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997. 389:300–305.